Extrahepatic Autoimmune Conditions Associated with Primary Biliary Cirrhosis
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
There is a paucity of information on extrahepatic autoimmune (EHA) conditions associated with primary biliary cirrhosis (PBC) and on the impact of EHA conditions on PBC patients' survival. Our goal was to assess the association between PBC and other autoimmune diseases and the impact of EHA conditions on the natural history of PBC. We took advantage of 361 consecutive PBC patients enrolled between 1975 and 2012 (22 males, 339 females; mean follow-up 8 ± 6.9 years). Any associated EHA conditions, PBC histological stage at diagnosis, biochemical data, physiological history, and extrahepatic malignancies developing during the follow-up were recorded. Survival was analyzed by means of Kaplan-Meier curves. Importantly, 221 patients (61.2 %) had at least one EHA conditions: 45 patients (20.4 %) had Hashimoto thyroiditis; 7 (3.2 %) had Graves' thyroiditis; 65 (29.4 %) had Raynaud's phenomenon; 124 (56.1 %) had Sjogren's syndrome; 8 (3.6 %) had systemic lupus erythematosus; 22 (9.9 %) had scleroderma; 22 (9.9 %) had rheumatoid arthritis; 18 (8.1 %) had cutaneous autoimmune diseases; 8 (3.6 %) had vasculitis; 5 (1.4 %) had celiac disease; and 25 (13.1 %) had other EHA conditions. The proportion of patients with associated EHA conditions enrolled during representative periods (1975-1980, 1981-1990, 1991-2000, 2001-2010, 2011-2012) remained stable. No differences emerged between patients with versus without EHA conditions in terms of mean age at PBC diagnosis, antimitochondrial antibody (AMA), or antinuclear antibody (ANA) positivity, histological stage at diagnosis, smoking habits, alcohol consumption, or BMI >25. Multiple logistic regression analysis showed that only female gender was significantly associated with positivity for EHA conditions (OR 4.8; 95 % CI 1.6-13.7, p = 0.004). The mean survival after the diagnosis of PBC was much the same in patients with and without EHA conditions. In conclusion, EHA conditions are often associated with PBC, especially in female patients, but they do not reduce patient survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Revised Criteria for the Classification of Rheumatoid Arthritis
Arnett, F. C. (1990) · Orthopaedic Nursing · doi:10.1097/00006416-199003000-00011 · Cited by 7,723
Petri, M., Orbai, A., Alarcón, G. S., Gordon, C., Merrill, J. T., Fortin, P. R., Bruce, I. N., Isenberg, D., Wallace, D. J., Nived, O., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34473 · Cited by 5,322
Polymyositis and Dermatomyositis: (First of Two Parts)
Bohan, A., & Peter, J. B. (1975) · New England Journal of Medicine · doi:10.1056/nejm197502132920706 · Cited by 5,059
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis
(2001) · Classic Papers in Rheumatology · doi:10.3109/9780203214237-95 · Cited by 3,950
Fox, R. I. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66990-5 · Cited by 1,828
Prognosis in primary biliary cirrhosis: Model for decision making
Dickson, R. E., Grambsch, P. M., Fleming, T. R., Fisher, L. D., & Langworthy, A. (1989) · Hepatology · doi:10.1002/hep.1840100102 · Cited by 816 · cited 1×
“The Mayo Risk Score, based on a combination of five variables (bilirubin, age, albumin, prothrombin time, and severity of edema) was calculated for all patients when their PBC was diagnosed [24].”
MethodConn, H. O., Leevy, C. M., Vlahcevic, Z. R., Rodgers, J. B., Maddrey, W. C., Seeff, L. B., & Levy, L. L. (1977) · PubMed · Cited by 641
Comparison of Lactulose and Neomycin in the Treatment of Chronic Portal-Systemic Encephalopathy
Conn, H. O., Leevy, C. M., Vlahcevic, Z. R., Rodgers, J. B., Maddrey, W. C., Seeff, L., & Levy, L. L. (1977) · Gastroenterology · doi:10.1016/s0016-5085(77)80135-2 · Cited by 628
Symposium: Advances in Liver Pathology [Abridged]: Primary Biliary Cirrhosis
Scheuer, P. J. (1967) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576706001205 · Cited by 557
Boberg, K. M., Chapman, R. W., Hirschfield, G. M., Lohse, A. W., Manns, M. P., & Schrumpf, E. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.09.002 · Cited by 555
Celaya, F. B. (1989) · Anales de Medicina Interna · Cited by 508
THE AMERICAN RHEUMATISM ASSOCIATION
Swaim, L. T. (1938) · Journal of the American Medical Association · doi:10.1001/jama.1938.72790470023037a · Cited by 506
Fox, R. I., Michelson, P., Casiano, C. A., Hayashi, J., & Stern, M. (2000) · Clinics in Dermatology · doi:10.1016/s0738-081x(00)00135-8 · Cited by 355
Concurrent Autoimmune Diseases in Patients With Autoimmune Hepatitis
Teufel, A., Weinmann, A., Kahaly, G. J., Centner, C., Piendl, A., Wörns, M., Lohse, A. W., Galle, P. R., & Kanzler, S. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181c74e0d · Cited by 215
Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis
Rigamonti, C., Shand, L. M., Feudjo, M., Bunn, C. C., Black, C. M., Denton, C. P., & Burroughs, A. K. (2006) · Gut · doi:10.1136/gut.2005.075002 · Cited by 194
Sjögren's Syndrome in Patients With Primary Biliary Cirrhosis
Tsianos, E. V., Hoofnagle, J. H., Fox, P. C., Alspaugh, M., Jones, A. E., Schafer, D. F., & Moutsopoulos, H. M. (1990) · Hepatology · doi:10.1002/hep.1840110504 · Cited by 171
Features of Sjögren's Syndrome in Primary Biliary Cirrhosis
ALARCÓN-SEGOVIA, D., DÍAZ-JOUANEN, E., & FISHBEIN, E. (1973) · Annals of Internal Medicine · doi:10.7326/0003-4819-79-1-31 · Cited by 158
Crowe, S. F., Christensen, E., Butler, J., Wheeler, P. G., Doniach, D., Keenan, J. P., & Williams, R. L. (1980) · Gastroenterology · doi:10.1016/s0016-5085(19)30497-4 · Cited by 148
Primary biliary cirrhosis and Sjögren’s syndrome: Autoimmune epithelitis
Selmi, C., Meroni, P. L., & Gershwin, M. E. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.11.005 · Cited by 145
Self-citation"Sicca Complex" in Liver Disease
Golding, P. L., Bown, R., Mason, A. M. S., & Taylor, E. (1970) · BMJ · doi:10.1136/bmj.4.5731.340 · Cited by 140
Lleo, A., Liao, J., Invernizzi, P., Zhao, M., Bernuzzi, F., Ma, L., Lanzi, G., Ansari, A. A., Coppel, R. L., Zhang, P., et al. (2012) · Hepatology · doi:10.1002/hep.24630 · Cited by 133
Review article: overlap syndromes and autoimmune liver disease
Trivedi, P. J., & Hirschfield, G. M. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05223.x · Cited by 126
Ando, Y., Yang, G.-X., Kenny, T. P., Kawata, K., Zhang, W., Huang, W., Leung, P. S. C., Lian, Z.-X., Okazaki, K., Ansari, A. A., et al. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.12.013 · Cited by 98
Self-citationLawson, A., West, J., Aithal, G. P., & Logan, R. F. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02328.x · Cited by 86
Tsuda, M., Zhang, W., Yang, G.-X., Tsuneyama, K., Ando, Y., Kawata, K., Park, O., Leung, P. S. C., Coppel, R. L., Ansari, A. A., et al. (2013) · Hepatology · doi:10.1002/hep.25829 · Cited by 86
Connective tissue diseases in primary biliary cirrhosis: A population-based cohort study
Wang, L., Zhang, F.-C., Chen, H., Zhang, X., Xu, D., Li, Y.-Z., Wang, Q., Gao, L., Yang, Y.-J., 孔芳, et al. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i31.5131 · Cited by 84
The limitations and hidden gems of the epidemiology of primary biliary cirrhosis
Podda, M., Selmi, C. F., Lleò, A., Moroni, L., & Invernizzi, P. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.06.015 · Cited by 76
Floreani, A., Caroli, D., Variola, A., Rizzotto, E. R., Antoniazzi, S., Chiaramonte, M., Cazzagon, N., Brombin, C., Salmaso, L., & Baldo, V. (2011) · Liver International · doi:10.1111/j.1478-3231.2010.02366.x · Cited by 69
Self-citationEnvironment and primary biliary cirrhosis: Electrophilic drugs and the induction of AMA
Leung, P. S. C., Wang, J., Naiyanetr, P., Kenny, T. P., Lam, K. S., Kurth, M. J., & Gershwin, M. E. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.12.007 · Cited by 66
Self-citationWang, Q., Selmi, C. F., Zhou, X., Qiu, D., Li, Z., Miao, Q., Chen, X., Wang, J., Krawitt, E. L., Gershwin, M. E., et al. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.10.004 · Cited by 66
Self-citationAntimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis
Chen, R. C. Y., Naiyanetr, P., Shu, S.-A., Wang, J., Yang, G.-X., Kenny, T. P., Guggenheim, K. C., Butler, J. D., Bowlus, C., Tao, M.-H., et al. (2013) · Hepatology · doi:10.1002/hep.26157 · Cited by 64
Floreani, A., Betterle, C., Baragiotta, A. M., Martini, S., Venturi, C., Basso, D., Pittoni, M., Chiarelli, S. M., & Guidetti, C. S. (2002) · Digestive and Liver Disease · doi:10.1016/s1590-8658(02)80145-1 · Cited by 60
Self-citationPlasma cells and the chronic nonsuppurative destructive cholangitis of primary biliary cirrhosis
Takahashi, T., Miura, T., Nakamura, J., Yamada, S., Miura, T., Yanagi, M., Matsuda, Y., Usuda, H., Emura, I., Tsuneyama, K., et al. (2012) · Hepatology · doi:10.1002/hep.24757 · Cited by 59
The immunopathology of liver granulomas in primary biliary cirrhosis
You, Z., Wang, Q., Bian, Z., Liu, Y., Han, X., Peng, Y., Shen, L., Chen, X., Qiu, D., Selmi, C., et al. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.05.022 · Cited by 57
Self-citationAnti-CD40 ligand monoclonal antibody delays the progression of murine autoimmune cholangitis
Tanaka, H., Yang, G.-X., Iwakoshi, N., Knechtle, S. J., Kawata, K., Tsuneyama, K., Leung, P., Coppel, R. L., Ansari, A. A., Joh, T., et al. (2013) · Clinical and Experimental Immunology · doi:10.1111/cei.12193 · Cited by 45
Self-citationNguyen, D. L., Juran, B. D., & Lazaridis, K. N. (2010) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2010.07.006 · Cited by 44
Ando, Y., Yang, G.-X., Tsuda, M., Kawata, K., Zhang, W., Nakajima, T., Tsuneyama, K., Leung, P., Lian, Z.-X., Okazaki, K., et al. (2012) · Hepatology · doi:10.1002/hep.25803 · Cited by 39
Jin, Q., Moritoki, Y., Lleo, A., Tsuneyama, K., Invernizzi, P., Moritoki, H., Kikuchi, K., Lian, Z.-X., Hirschfield, G. M., Ansari, A. A., et al. (2012) · Hepatology · doi:10.1002/hep.25511 · Cited by 37
Spadaro, A., Scrivo, R., Riccieri, V., & Valesini, G. (2007) · Joint Bone Spine · doi:10.1016/j.jbspin.2007.03.003 · Cited by 35
Clinical management of autoimmune biliary diseases
Imam, M. H., Talwalkar, J. A., & Lindor, K. D. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.06.014 · Cited by 19
Kubo, S., Iwata, S., Saito, K., & Tanaka, Y. (2011) · Joint Bone Spine · doi:10.1016/j.jbspin.2011.04.014 · Cited by 12
Cited by
Lindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913
Carey, E. J., Ali, A. H., & Lindor, K. D. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00154-3 · Cited by 735
Lleo, A., Wang, G.-Q., Gershwin, M. E., & Hirschfield, G. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31607-x · Cited by 253
Self-citationCurrent understanding of primary biliary cholangitis
Tanaka, A. (2021) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0028 · Cited by 158
The roles of PPARγ and its agonists in autoimmune diseases: A comprehensive review
Liu, Y., Wang, J., Luo, S., Zhan, Y., & Lu, Q. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102510 · Cited by 157
Metadata
- Authors
- Floreani, A., Franceschet, I., Cazzagon, N., Spinazzè, A., Buja, A., Furlan, P., Baldo, V., & Gershwin, M. E.
- Affiliations
- University of Padua (IT)
- University of California, Davis (US)
- Corresponding author
- Floreani, Annarosa
- ORCID
- Venue
- Clinical Reviews in Allergy & Immunology
- Published
- 2014-05-09
- Volume
- 48
- Issue
- 2-3
- Pages
- 192-197
- ISSN
- 1080-0549 (ISSN-L)
- 1559-0267
- OpenAlex
- W1980881293
- Cited by
- 188
- References
- 42
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 25 · 2023: 20 · 2022: 11 · 2021: 18 · 2020: 16 · 2019: 15 · 2018: 19 · 2017: 19 · 2016: 7 · 2015: 20 · 2014: 4
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Clinical Reviews in Allergy & Immunology (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Keywords
- primary biliary cirrhosis, extrahepatic autoimmune diseases, autoimmune disease association, Hashimoto's thyroiditis, Sjögren's syndrome, Raynaud's phenomenon, systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, vasculitis, celiac disease, survival, sex differences, natural history (disease), antimitochondrial antibodies
- MeSH terms
- Adult, Aged, Animals, Autoimmune Diseases, Female, Humans, Liver Cirrhosis, Biliary, Male, Middle Aged, Autoimmunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.